JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

Search

Phibro Animal Health Corp

Fermé

SecteurSoins de santé

54.9 0.62

Résumé

Variation du prix de l'action

24h

Actuel

Min

54.45

Max

55.25

Chiffres clés

By Trading Economics

Revenu

932K

27M

Ventes

10M

374M

P/E

Moyenne du Secteur

25.004

60.328

Rendement du dividende

0.84

Marge bénéficiaire

7.344

Employés

2,475

EBITDA

4.7M

67M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

-6.18% downside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.84%

2.24%

Prochains Résultats

6 mai 2026

Date du Prochain Dividende

24 juin 2026

Date du Prochain Détachement de Dividende

3 juin 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

592M

2.3B

Ouverture précédente

54.28

Clôture précédente

54.9

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Phibro Animal Health Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 avr. 2026, 19:19 UTC

Acquisitions, Fusions, Rachats

Intertek Group Rejects EQT's Revised Offer

24 avr. 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Scoring the Cook Era -- Barrons.com

24 avr. 2026, 20:51 UTC

Acquisitions, Fusions, Rachats

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 avr. 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Financial Services Roundup: Market Talk

24 avr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

24 avr. 2026, 20:39 UTC

Acquisitions, Fusions, Rachats

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 avr. 2026, 20:09 UTC

Résultats

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 avr. 2026, 19:48 UTC

Market Talk
Principaux Événements d'Actualité

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 avr. 2026, 19:25 UTC

Acquisitions, Fusions, Rachats

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 avr. 2026, 19:25 UTC

Acquisitions, Fusions, Rachats

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 avr. 2026, 19:22 UTC

Résultats

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 avr. 2026, 19:06 UTC

Résultats

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 avr. 2026, 19:05 UTC

Market Talk

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 avr. 2026, 18:30 UTC

Acquisitions, Fusions, Rachats

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 avr. 2026, 18:28 UTC

Acquisitions, Fusions, Rachats

Intertek Rejects Revised EQT Offer

24 avr. 2026, 18:12 UTC

Market Talk

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 avr. 2026, 18:06 UTC

Market Talk

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 avr. 2026, 17:42 UTC

Résultats

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 avr. 2026, 17:28 UTC

Résultats

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

24 avr. 2026, 17:28 UTC

Market Talk

Crypto Fear and Greed Index Slides Back to Neutral -- Market Talk

24 avr. 2026, 17:12 UTC

Market Talk

Global Equities Roundup: Market Talk

24 avr. 2026, 17:11 UTC

Market Talk

Apple Seen Gaining Market Share Despite Memory Crunch -- Market Talk

24 avr. 2026, 17:09 UTC

Market Talk
Résultats

Intel Seen With Stronger Long-Term Earnings Power -- Market Talk

24 avr. 2026, 17:09 UTC

Acquisitions, Fusions, Rachats

Organon Stock Surges on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 avr. 2026, 17:06 UTC

Résultats
Acquisitions, Fusions, Rachats

Correction to Advanced Micro Devices Stock Gets Upgraded to Buy. Why It's the Big Winner of Intel Earnings. -- Barrons.com

24 avr. 2026, 16:51 UTC

Résultats
Acquisitions, Fusions, Rachats

Two Big Loan Defaults Add to Pain in Private-Credit Funds -- WSJ

24 avr. 2026, 16:20 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

24 avr. 2026, 16:20 UTC

Market Talk
Principaux Événements d'Actualité

Financial Services Roundup: Market Talk

24 avr. 2026, 16:20 UTC

Market Talk
Résultats

Auto & Transport Roundup: Market Talk

24 avr. 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

Comparaison

Variation de prix

Phibro Animal Health Corp prévision

Objectif de Prix

By TipRanks

-6.18% baisse

Prévisions sur 12 Mois

Moyen 51.75 USD  -6.18%

Haut 62 USD

Bas 38 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

4 ratings

1

Achat

2

Maintien

1

Vente

Score Technique

By Trading Central

17 / N/ASupport & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Weak Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
help-icon Live chat